Design, synthesis and antitumor activities of novel bis-aryl ureas derivatives as Raf kinase inhibitors

…, W Huang, Y Zhao, Z Yao, S Yu, S Yuan, F Jiang…

Index: Zhan, Wenhu; Li, Yanyang; Huang, Weiping; Zhao, Yanjin; Yao, Zhenglin; Yu, Shanyou; Yuan, Shoujun; Jiang, Falong; Yao, Shan; Li, Shuxin Bioorganic and Medicinal Chemistry, 2012 , vol. 20, # 14 p. 4323 - 4329

Full Text: HTML

Citation Number: 12

Abstract

A series of novel bis-aryl ureas containing trifluoromethyl imidazolyl group targeting Raf kinase were designed and synthesized based on the lead compound of Sorafenib. All the prepared compounds were evaluated for their in vitro antiproliferative activities against three human cancer cell lines including MDA-MB-231 (breast), BGC-823 (gastric), and SMMC- 7721 (liver). Several compounds from the series exhibited excellent antitumor activities ...

Related Articles:

Cytochrome P450-mediated biotransformation of sorafenib and its N-oxide metabolite: implications for cell viability and human toxicity

[Varlet, Didier; Fourmaintraux, Eric; Depreux, Patrick; Lesieur, Daniel Heterocycles, 2000 , vol. 53, # 4 p. 797 - 804]

A simple procedure for the preparation of 2??cyano??4??chloropyridines

[Veerareddy, Arava; Surendrareddy, Gogireddy; Dubey Journal of Heterocyclic Chemistry, 2011 , vol. 48, # 4 p. 961 - 964]

More Articles...